Variable | Harmonic (n = 36) | Electrocautery (n = 36) | p |
---|---|---|---|
- Age (years) | 51.8 ± 6.5 | 52.5 ± 7.8 | 0.707a |
- BMI | 29.5 ± 3.1 | 29.6 ± 5.4 | 0.206 a |
- Comorbidities | |||
HTN | 16 (44.4%) | 18 (50%) | 0.317 b |
DM | 12 (33.3%) | 14 (38.9%) | 0.523 b |
CLD | 11 (30.6%) | 13 (36.1%) | 0.628 b |
- Smoking | 5 (13.9%) | 3 (8.3%) | 0.427 b |
- Family history | |||
Positive | 4 (11.1%) | 8 (22.2%) | 0.316 b |
- Parity | |||
Nullpara | 4 (11.1%) | 2 (5.6%) | 0.716 b |
Multipara | 32 (88.9%) | 34 (94.4%) | 0.521 b |
- Breast Weight (G) | 1511 ± 584.5 | 1641 ± 828.6 | 0.139 a |
- Clinical TNM stage | |||
Stage I | 4 (11.1%) | 2 (5.6%) | 0.637 b |
Stage II | 26 (72.2%) | 30 (83.3%) | |
Stage III | 6 (16.7%) | 4 (11.1%) | |
-AJCC tumor staging | |||
Stage I A | 1 (2.8%) | 1 (2.8%) | 0.327 b |
Stage I B | 3 (8.3%) | 1 (2.8%) | |
Stage II A | 5 (13.9%) | 7 (19.4%) | |
Stage II B | 21 (58.3%) | 23 (63.9%) | |
Stage III A | 5 (13.9%) | 2 (5.5%) | |
Stage III B | 1 (2.8%) | 2 (5.5%) | |
- No. of lymph nodes retrieved d | 21 (11 – 32) | 17 (10 – 27) | 0.262c |
- Neoadjuvant therapy | 5 (13.9%) | 6 (16.7%) | 0.745 b |
- Histology | |||
Ductal carcinoma | 34 (94.4%) | 32 (88.9%) | 0.243 b |
Lobular | 2 (5.6%) | 4 (11.1%) |